Nuvectis Pharma Inc.
(NVCT)
undefined
undefined%
At close: undefined
4.70
-0.69%
After-hours Dec 13, 2024, 04:00 PM EST
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to
free cash flow ratio, price per earnings, and much more.
Year | FY23 | FY22 | FY21 | FY20 |
Net Income | -22.26M | -19.09M | -12.89M | -24.00K |
Depreciation & Amortization | - | - | - | - |
Stock-Based Compensation | 4.71M | 1.71M | 1.89M | - |
Other Working Capital | 1.88M | -321.00K | -91.00K | 10.00K |
Other Non-Cash Items | -139.00K | -2.43M | 307.00K | 24.00K |
Deferred Income Tax | - | - | - | - |
Change in Working Capital | 1.74M | 3.82M | 1.49M | 10.00K |
Operating Cash Flow | -15.95M | -13.56M | -9.50M | 24.00K |
Capital Expenditures | - | - | - | - |
Acquisitions | - | - | - | - |
Purchase of Investments | - | - | - | - |
Sales Maturities Of Investments | - | - | - | - |
Other Investing Acitivies | - | - | - | - |
Investing Cash Flow | - | - | - | - |
Debt Repayment | - | - | - | - |
Common Stock Repurchased | - | - | - | - |
Dividend Paid | - | - | - | - |
Other Financial Acitivies | 9.80M | -4.07M | 15.25M | - |
Financial Cash Flow | 15.09M | 27.81M | 15.25M | - |
Net Cash Flow | -867.00K | 14.25M | 5.74M | 24.00K |
Free Cash Flow | -15.95M | -13.56M | -9.50M | 24.00K |